111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-6.07%
Revenue decline while CX shows 13.06% growth. Joel Greenblatt would examine competitive position erosion.
No Data
No Data available this quarter, please select a different quarter.
-6.07%
Gross profit decline while CX shows 23.58% growth. Joel Greenblatt would examine competitive position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-6.07%
EBITDA decline while CX shows 75.20% growth. Joel Greenblatt would examine position.
No Data
No Data available this quarter, please select a different quarter.
-6.07%
Operating income decline while CX shows 70.77% growth. Joel Greenblatt would examine position.
No Data
No Data available this quarter, please select a different quarter.
100.00%
Similar other expenses growth to CX's 110.55%. Walter Schloss would investigate industry patterns.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-48.41%
Tax expense reduction while CX shows 95.05% growth. Joel Greenblatt would examine advantage.
48.41%
Net income growth while CX declines. John Neff would investigate advantages.
57.99%
Net margin growth while CX declines. John Neff would investigate advantages.
60.00%
EPS growth while CX declines. John Neff would investigate advantages.
60.00%
Diluted EPS growth while CX declines. John Neff would investigate advantages.
-7.24%
Share count reduction while CX shows 0.00% change. Joel Greenblatt would examine strategy.
-7.24%
Diluted share reduction while CX shows 0.00% change. Joel Greenblatt would examine strategy.